Diabetes and fracture healing: the skeletal effects of diabetic drugs

Bibliography

• NHS. Diabetic Prevelence. 2011. Available from: www.diabetes.nhs.uk [Cited 18 April 2011]
   Google Scholar
• Chesser TJS, Hammett RB, Norton SA. Orthopaedic trauma in the obese patient. Inj Int J Care Injured 2010;41:247-52
   PubMed Web of Science ®Google Scholar
• NHS H. NHS hospital episode staistics. 2011. Available from: www.hesonline.nhs.uk [Cited 18 April 2011]
   Google Scholar
• Zuurmond RG, van Wijhe W, van Raay JJAM, High incidence of complications and poor clinical outcome in the operative treatment of periprosthetic femoral fractures: An analysis of 71 cases. Inj Int J Care Injured 2010;41:629-33
   PubMed Web of Science ®Google Scholar
• Sammour T, Kahokehr A, Caldwell S, Hill AG, Venous glucose and arterial lactate as biochemical predictors of mortality in clinically severely injured trauma patients - A comparison with ISS and TRISS. Inj Int J Care Injured 2009;40:104-8
   PubMed Web of Science ®Google Scholar
• Bouillon R. Diabetic bone disease. Calcif Tissue Int 1991;49:155-60
   PubMed Web of Science ®Google Scholar
• Janghorbani M, Van Dam RM, Willett WC, Hu FB, Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007;166:495
   PubMed Web of Science ®Google Scholar
• Cozen L. Does diabetes delay fracture healing? Clin Orthop Relat Res 1972;82:134
   PubMed Web of Science ®Google Scholar
• Loder RT. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res 1988;232:210
   PubMed Web of Science ®Google Scholar
• Roszer T. Inflammation as death or life signal in diabetic fracture healing. Inflamm Res 2010;60:3-10
   PubMed Web of Science ®Google Scholar
• Kayal RA, Siqueira M, Alblow J, TNF mediates diabetes enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis Through FOXO1. J Bone Miner Res 2010;25:1604-15
   PubMed Web of Science ®Google Scholar
• Follak N, Kloting I, Wolf E, Follak H, Improving metabolic control reverses the histomorphometric and biomechanical abnormalities of an experimentally induced bone defect in spontaneously diabetic rats. Calcif Tissue Int 2004;74:551-60
   PubMed Web of Science ®Google Scholar
• Santana RB, Xu L, Chase L, A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes 2003;52:1502
   PubMed Web of Science ®Google Scholar
• Fowlkes JL, Bunn RC, Liu L, Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus. Endocrinology 2008;149:1697
   PubMed Web of Science ®Google Scholar
• Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 2004;351:1106-18
   PubMed Web of Science ®Google Scholar
• Ali AA, Weinstein RS, van Stewart SA, Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 2005;146:1226
   PubMed Web of Science ®Google Scholar
• Shockley KR, Lazarenko OP, Czernik PJ, PPAR 2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem 2009;106:232
   PubMed Web of Science ®Google Scholar
• Lecka-Czernik B. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis. Curr osteoporos rep 2010;8:178-84
   PubMedGoogle Scholar
• Lin TH, Yang RS, Tang CH, PPAR [gamma] inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. Bone 2007;41:562-74
   PubMed Web of Science ®Google Scholar
• Grey A, Bolland M, Gamble G, The peroxisome proliferator-activated receptor-{gamma} agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 2007;92:1305
   PubMed Web of Science ®Google Scholar
• Berberoglu Z, Gursoy A, Bayraktar N, Rosiglitazone decreases serum bone-specific alkaline phosphatase activity in postmenopausal diabetic women. J Clin Endocrinol Metab 2007;92:3523
   PubMed Web of Science ®Google Scholar
• Beam HA, Russell Parsons J, Lin SS. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res 2002;20:1210-16
   PubMed Web of Science ®Google Scholar
• Kayal RA, Alblowi J, McKenzie E, Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. Bone 2009;44:357-63
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Nakamura K, Inoue H. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. Med Hypotheses 2005;65:1013-15
   PubMed Web of Science ®Google Scholar
• Saito M, Marumo K. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int 2006;17:1514-23
   PubMed Web of Science ®Google Scholar
• Follak N, Kloting I, Merk H. Influence of diabetic metabolic state on fracture healing in spontaneously diabetic rats. Diabetes Metab Res Rev 2005;21:288-96
   PubMed Web of Science ®Google Scholar
• Arlt W, Auchus RJ, Miller WL. Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3 -hydroxysteroid dehydrogenase. J Biol Chem 2001;276:16767
   PubMed Web of Science ®Google Scholar
• Berberoglu Z, Yazici AC, Demirag NG. Effects of rosiglitazone on bone mineral density and remodelling parameters in Postmenopausal diabetic women: a 2 year follow up study. Clin Endocrinol (Oxf) 2010;73:305-12
   PubMed Web of Science ®Google Scholar
• Cortizo AM, Sedlinsky C, McCarthy AD, Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur J Pharmacol 2006;536:38-46
   PubMed Web of Science ®Google Scholar
• Kanazawa I, Yamaguchi T, Yano S, Metformin enhances the differentiation and mineralisation of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression. Biochem Biophys Res Commun 2008;375:414-19
   PubMed Web of Science ®Google Scholar
• Molinuevo MS, Schurman L, McCarthy AD, Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies. J Bone Miner Res 2010;25:211-21
   PubMed Web of Science ®Google Scholar
• Gao Y, Li Y, Xue J, Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats. Eur J Pharmacol 2010;635:231-6
   PubMed Web of Science ®Google Scholar